Fenofibrate is a lipid-lowering agent that activates peroxisome proliferator-activated receptors (PPARα) to reduce triglycerides and increase HDL cholesterol. It is especially useful in managing mixed dyslipidemia and high triglyceride levels, often in combination with statins.